multihance injection 15 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
multihance injection 20 ml
dch auriga singapore - gadobenate dimeglumine - injection - 529 mg/ml - gadobenate dimeglumine 529 mg/ml
flunixin meglumine
neove pharma australia pty limited - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent
flunixin meglumine
mavlab pty. ltd. - flunixin meglumine - unknown - flunixin meglumine benzene active 0.0 - active constituent
hexasol- oxytetracycline, flunixin meglumine injection, solution
norbrook laboratories limited - oxytetracycline (unii: x20i9en955) (oxytetracycline - unii:x20i9en955), flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - oxytetracycline 300 mg in 1 ml - for the treatment of bacterial pneumonia associated with pasteurella spp. and for the control of associated pyrexia in beef and non-lactating dairy cattle. do not use in animals showing hypersensitivity to either flunixin meglumine or oxytetracycline.
conray- iothalamate meglumine injection
liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 600 mg in 1 ml - conray is indicated for use in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography. conray may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic ct scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone, and in supplying additional features of the lesions. in oth
conray 30 iothalamate meglumine injection
liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 300 mg in 1 ml
md-76r diatrizoate meglumine and sodium solution
liebel-flarsheim company llc - diatrizoate meglumine (unii: 3x9mr4n98u) (diatrizoic acid - unii:5uvc90j1lk) - diatrizoate meglumine 660 mg in 1 ml
conray 43- iothalamate meglumine injection
liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 430 mg in 1 ml - conray 43 is indicated for use in lower extremity venography, intravenous infusion urography, contrast enhancement of computed tomographic brain images and arterial digital subtraction angiography. conray 43 may also be used for enhancement of computed tomographic scans performed for detection and evaluation of lesions in the liver, pancreas, kidneys, abdominal aorta, mediastinum, abdominal cavity and retroperitoneal space. continuous or multiple scans separated by intervals of 1 to 3 seconds during the first 30 to 90 seconds post-injection of the contrast medium (dynamic ct scanning) may provide enhancement of diagnostic significance, and may be of benefit in establishing diagnoses of certain lesions in these sites with greater assurance than is possible with ct alone and in supplying additional features of the lesions. in other cases, the contrast agent may allow visualization of lesions not seen with ct alone, or may help to define suspicious lesions seen with unenhanced ct (see clinical pharmacology). su
cysto-conray ii- iothalamate meglumine injection
liebel-flarsheim company llc - iothalamate meglumine (unii: xuw72gop7w) (iothalamic acid - unii:16chd79mix) - iothalamate meglumine 172 mg in 1 ml - cysto-conray ii is indicated for use in retrograde cystography and cystourethrography. see warnings concerning inadvertant intrathecal administration.